East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Feb 16, 2017
0
0
(HealthDay)—For women with early-stage, hormone receptor-positive invasive breast cancer, initiation of cholesterol-lowering medication (CLM) during endocrine therapy is associated with improved survival and distant recurrence-free ...
Feb 15, 2017
0
10
When flawed clinical research is reported in the media with hype and sensationalism, it has the potential to have a devastating effect on patients, physicians, the scientific community and eventually society as a whole.
Dec 8, 2016
0
0
In patients with invasive breast cancer treated in a general community health care setting, tamoxifen therapy was associated with reduced risTamoxifen, AI therapies linked to reduced risk for contralateral breast cancer in ...
Oct 6, 2016
0
0
An enriched hops extract activates a chemical pathway in cells that could help prevent breast cancer, according to new laboratory findings from the UIC/NIH Center for Botanical Dietary Supplements Research at the University ...
Jul 11, 2016
0
14
Compared with receiving chemotherapy alone, women with breast cancer who also received the hormonal drug triptorelin to achieve ovarian suppression had a higher long-term probability of ovarian function recovery, without ...
Dec 22, 2015
0
2
Treatment with endocrine therapy and radiation therapy as part of breast conservation is the current standard of care for women with hormone-receptor positive (HR+) invasive breast cancer. A new study by researchers at Fox ...
Sep 16, 2014
0
0
Mucormycosis is a deadly infection that strikes people with weakened immune systems when certain types of fungi, called Mucorales, invade the patients' cells. A novel protein on the surface of the Mucorales cells, called ...
Dec 20, 2013
0
0
Understanding how the protein km23-1 enables in the spread of colon cancer may lead to new treatments for the disease, according to researchers at Penn State College of Medicine.
Jun 27, 2013
0
0
Prostate screening tests detect prostate cancer early, but questions about whether the tests do more harm than good have made them one of the most hotly debated areas of medicine.
Jun 7, 2013
0
0
